17-44913374-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_002055.5(GFAP):c.675C>T(p.Asp225Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0002 in 1,614,182 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0012 ( 1 hom., cov: 33)
Exomes 𝑓: 0.000097 ( 0 hom. )
Consequence
GFAP
NM_002055.5 synonymous
NM_002055.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.416
Genes affected
GFAP (HGNC:4235): (glial fibrillary acidic protein) This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 17-44913374-G-A is Benign according to our data. Variant chr17-44913374-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 323616.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-44913374-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.416 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00119 (181/152322) while in subpopulation AFR AF= 0.00409 (170/41586). AF 95% confidence interval is 0.00359. There are 1 homozygotes in gnomad4. There are 78 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 181 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFAP | NM_002055.5 | c.675C>T | p.Asp225Asp | synonymous_variant | 4/9 | ENST00000588735.3 | NP_002046.1 | |
GFAP | NM_001363846.2 | c.675C>T | p.Asp225Asp | synonymous_variant | 4/10 | NP_001350775.1 | ||
GFAP | NM_001242376.3 | c.675C>T | p.Asp225Asp | synonymous_variant | 4/7 | NP_001229305.1 | ||
GFAP | NM_001131019.3 | c.675C>T | p.Asp225Asp | synonymous_variant | 4/8 | NP_001124491.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFAP | ENST00000588735.3 | c.675C>T | p.Asp225Asp | synonymous_variant | 4/9 | 1 | NM_002055.5 | ENSP00000466598.2 |
Frequencies
GnomAD3 genomes AF: 0.00119 AC: 181AN: 152204Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
181
AN:
152204
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000239 AC: 60AN: 251398Hom.: 0 AF XY: 0.000147 AC XY: 20AN XY: 135882
GnomAD3 exomes
AF:
AC:
60
AN:
251398
Hom.:
AF XY:
AC XY:
20
AN XY:
135882
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000971 AC: 142AN: 1461860Hom.: 0 Cov.: 32 AF XY: 0.0000894 AC XY: 65AN XY: 727238
GnomAD4 exome
AF:
AC:
142
AN:
1461860
Hom.:
Cov.:
32
AF XY:
AC XY:
65
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00119 AC: 181AN: 152322Hom.: 1 Cov.: 33 AF XY: 0.00105 AC XY: 78AN XY: 74480
GnomAD4 genome
AF:
AC:
181
AN:
152322
Hom.:
Cov.:
33
AF XY:
AC XY:
78
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 11, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | GFAP: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at